Cargando…

Using Cost-Effectiveness Analysis to Address Health Equity Concerns

This articles serves as a guide to using cost-effectiveness analysis (CEA) to address health equity concerns. We first introduce the "equity impact plane," a tool for considering trade-offs between improving total health—the objective underpinning conventional CEA—and equity objectives, su...

Descripción completa

Detalles Bibliográficos
Autores principales: Cookson, Richard, Mirelman, Andrew J., Griffin, Susan, Asaria, Miqdad, Dawkins, Bryony, Norheim, Ole Frithjof, Verguet, Stéphane, J. Culyer, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340318/
https://www.ncbi.nlm.nih.gov/pubmed/28237196
http://dx.doi.org/10.1016/j.jval.2016.11.027
_version_ 1782512807168704512
author Cookson, Richard
Mirelman, Andrew J.
Griffin, Susan
Asaria, Miqdad
Dawkins, Bryony
Norheim, Ole Frithjof
Verguet, Stéphane
J. Culyer, Anthony
author_facet Cookson, Richard
Mirelman, Andrew J.
Griffin, Susan
Asaria, Miqdad
Dawkins, Bryony
Norheim, Ole Frithjof
Verguet, Stéphane
J. Culyer, Anthony
author_sort Cookson, Richard
collection PubMed
description This articles serves as a guide to using cost-effectiveness analysis (CEA) to address health equity concerns. We first introduce the "equity impact plane," a tool for considering trade-offs between improving total health—the objective underpinning conventional CEA—and equity objectives, such as reducing social inequality in health or prioritizing the severely ill. Improving total health may clash with reducing social inequality in health, for example, when effective delivery of services to disadvantaged communities requires additional costs. Who gains and who loses from a cost-increasing health program depends on differences among people in terms of health risks, uptake, quality, adherence, capacity to benefit, and—crucially—who bears the opportunity costs of diverting scarce resources from other uses. We describe two main ways of using CEA to address health equity concerns: 1) equity impact analysis, which quantifies the distribution of costs and effects by equity-relevant variables, such as socioeconomic status, location, ethnicity, sex, and severity of illness; and 2) equity trade-off analysis, which quantifies trade-offs between improving total health and other equity objectives. One way to analyze equity trade-offs is to count the cost of fairer but less cost-effective options in terms of health forgone. Another method is to explore how much concern for equity is required to choose fairer but less cost-effective options using equity weights or parameters. We hope this article will help the health technology assessment community navigate the practical options now available for conducting equity-informative CEA that gives policymakers a better understanding of equity impacts and trade-offs.
format Online
Article
Text
id pubmed-5340318
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-53403182017-03-13 Using Cost-Effectiveness Analysis to Address Health Equity Concerns Cookson, Richard Mirelman, Andrew J. Griffin, Susan Asaria, Miqdad Dawkins, Bryony Norheim, Ole Frithjof Verguet, Stéphane J. Culyer, Anthony Value Health Article This articles serves as a guide to using cost-effectiveness analysis (CEA) to address health equity concerns. We first introduce the "equity impact plane," a tool for considering trade-offs between improving total health—the objective underpinning conventional CEA—and equity objectives, such as reducing social inequality in health or prioritizing the severely ill. Improving total health may clash with reducing social inequality in health, for example, when effective delivery of services to disadvantaged communities requires additional costs. Who gains and who loses from a cost-increasing health program depends on differences among people in terms of health risks, uptake, quality, adherence, capacity to benefit, and—crucially—who bears the opportunity costs of diverting scarce resources from other uses. We describe two main ways of using CEA to address health equity concerns: 1) equity impact analysis, which quantifies the distribution of costs and effects by equity-relevant variables, such as socioeconomic status, location, ethnicity, sex, and severity of illness; and 2) equity trade-off analysis, which quantifies trade-offs between improving total health and other equity objectives. One way to analyze equity trade-offs is to count the cost of fairer but less cost-effective options in terms of health forgone. Another method is to explore how much concern for equity is required to choose fairer but less cost-effective options using equity weights or parameters. We hope this article will help the health technology assessment community navigate the practical options now available for conducting equity-informative CEA that gives policymakers a better understanding of equity impacts and trade-offs. Elsevier 2017-02 /pmc/articles/PMC5340318/ /pubmed/28237196 http://dx.doi.org/10.1016/j.jval.2016.11.027 Text en © 2017 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Elsevier Inc. All rights reserved. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Cookson, Richard
Mirelman, Andrew J.
Griffin, Susan
Asaria, Miqdad
Dawkins, Bryony
Norheim, Ole Frithjof
Verguet, Stéphane
J. Culyer, Anthony
Using Cost-Effectiveness Analysis to Address Health Equity Concerns
title Using Cost-Effectiveness Analysis to Address Health Equity Concerns
title_full Using Cost-Effectiveness Analysis to Address Health Equity Concerns
title_fullStr Using Cost-Effectiveness Analysis to Address Health Equity Concerns
title_full_unstemmed Using Cost-Effectiveness Analysis to Address Health Equity Concerns
title_short Using Cost-Effectiveness Analysis to Address Health Equity Concerns
title_sort using cost-effectiveness analysis to address health equity concerns
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340318/
https://www.ncbi.nlm.nih.gov/pubmed/28237196
http://dx.doi.org/10.1016/j.jval.2016.11.027
work_keys_str_mv AT cooksonrichard usingcosteffectivenessanalysistoaddresshealthequityconcerns
AT mirelmanandrewj usingcosteffectivenessanalysistoaddresshealthequityconcerns
AT griffinsusan usingcosteffectivenessanalysistoaddresshealthequityconcerns
AT asariamiqdad usingcosteffectivenessanalysistoaddresshealthequityconcerns
AT dawkinsbryony usingcosteffectivenessanalysistoaddresshealthequityconcerns
AT norheimolefrithjof usingcosteffectivenessanalysistoaddresshealthequityconcerns
AT verguetstephane usingcosteffectivenessanalysistoaddresshealthequityconcerns
AT jculyeranthony usingcosteffectivenessanalysistoaddresshealthequityconcerns